Advertisement

More articles from Erratum

You have access
Correction to “CCAAT/Enhancer-Binding Protein β (Nuclear Factor for Interleukin 6) Transactivates the Human MDR1 Gene by Interaction with an Inverted CCAAT Box in Human Cancer Cells”
Molecular Pharmacology November 2018, 94 (5) 1311; DOI: https://doi.org/10.1124/mol.117.906err
You have access
Correction to “Identification of AICP as a GluN2C-Selective N-Methyl-D-Aspartate Receptor Superagonist at the GluN1 Glycine Site”
Molecular Pharmacology October 2018, 94 (4) 1101-1102; DOI: https://doi.org/10.1124/mol.117.108944err
You have access
Correction to “Agonist-Dependent and-Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes”
Molecular Pharmacology August 2018, 94 (2) 895; DOI: https://doi.org/10.1124/mol.117.108555err
You have access
Correction to “Investigation into the Mechanism of Homo- and Heterodimerization of Angiotensin-Converting Enzyme”
Molecular Pharmacology May 2018, 93 (5) 416; DOI: https://doi.org/10.1124/mol.117.110866err
You have access
Correction to “Novel Small Molecule JP-153 Targets the Src-FAK-Paxillin Signaling Complex to Inhibit VEGF-Induced Retinal Angiogenesis”
Molecular Pharmacology December 2017, 92 (6) 627; DOI: https://doi.org/10.1124/mol.116.105031err
You have access
Correction to “G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer”
Molecular Pharmacology December 2017, 92 (6) 628; DOI: https://doi.org/10.1124/mol.116.107185err
You have access
Correction to “The Emerging Role of Cable1 in Cancer and Other Diseases”
Molecular Pharmacology December 2017, 92 (6) 629; DOI: https://doi.org/10.1124/mol.116.107730err
You have access
Correction to “A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation”
Molecular Pharmacology November 2017, 92 (5) 501; DOI: https://doi.org/10.1124/mol.117.108787err
You have access
Correction to “6-Mercaptopurine Decreases the Bcl-2/Bax Ratio and Induces Apoptosis in Activated Splenic B Lymphocytes”
Molecular Pharmacology October 2017, 92 (4) 500; DOI: https://doi.org/10.1124/mol.111.513err
You have access
Correction to “The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes”
Molecular Pharmacology July 2017, 92 (1) 100; DOI: https://doi.org/10.1124/mol.116.107904err

Pages